BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  A Bright Day for Two Companies as New CEOs Announced

  On Wednesday, Sage Therapeutics and Samsung Biologics announced that they had found just that in their new chief executive officers.

  December 17, 2020

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Drug Development

  COVID-19 Vaccine Rollout Glitches: Extra Doses, Supply Chain, Snowstorm and Anaphylaxis

  As Pfizer-BioNTech and the U.S. government begin the historic rollout of COVID-19 vaccine distribution around the U.S. and the world, there have been a few glitches. This isn’t unexpected.

  December 17, 2020

   · 

  6 min read

   · 

  Mark Terry
• 

  Business

  Thermo Fisher Invests in Gene Therapy Future with Huge Expansions

  The company is significantly expanding its footprint with new facilities in the United States and in Europe.

  December 17, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Neuro Biotech Scooped Up by Novartis in $770 Million Deal

  Novartis is acquiring Cambridge, Massachusetts-based Cadent Therapeutics for $210 million up front and a possible $560 million in milestone payments.

  December 17, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Job Trends

  AstraZeneca Closes in on Potential UK Vaccine Authorization and Other COVID-19 News

  Despite some setbacks, the company anticipates its vaccine could be available for use in the United Kingdom within the next several weeks.

  December 17, 2020

   · 

  4 min read

   · 

  Alex Keown
• 

  BioMidwest

  Research Roundup: Depression, Inflammation, Menopause and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  December 17, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Building Better Virus Countermeasures — J&J’s BLUE KNIGHT™ Symposium Shows What’s Coming

  With the first wave of vaccines gaining regulatory approval, nascent biotech companies are looking toward the future, exploring new technologies to make vaccines more effective for more people.

  December 17, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Months of Work Hang in the Balance as Moderna’s COVID-19 Vaccine Awaits AdComm Vote

  A critical vote is set to take place today amongst those on a U.S. Food and Drug Administration advisory panel in regard to the COVID-19 vaccine from Moderna.

  December 17, 2020

   · 

  2 min read

   · 

  Krystle Vermes
• 

  Career Advice

  Which Types of Continued Learning Can You List on a Resume?

  While continued learning opportunities are easy to access and many are quite affordable, the real question is, can you list these courses on your resume? And if you do so, what will recruiters in the biotech field think of them?

  December 17, 2020

   · 

  3 min read

   · 

  Kymberlie Krieger
• 

  Policy

  Four New Drugs Keeping the FDA Busy Today

  Applications include a nasal COVID-19 vaccine, an NSCLC drug, respiratory infection drug and a treatment for a chronic inflammation of the esophagus.

  December 17, 2020

   · 

  4 min read

   · 

  Kate Goodwin